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MLS301 – Transfusion Medicine 
DURATION 
 
Reading Time: 10 minutes 
Writing Time: 120 minutes 
 
INSTRUCTIONS TO CANDIDATES 
 
Section A:  
Suggested Time:  
50 mins 
Multiple Choice Questions: Answer ALL 50 questions. 
Marks as indicated on paper (Total marks = 50) 
Section B:  
Suggested Time:  
70 mins 
Short Answer Questions: Answer ALL 9 questions. 
Marks as indicated on paper. (Total marks = 50) 
 
EXAM CONDITIONS 
You may begin writing from the commencement of the examination session.  The reading time indicated above is 
provided as a guide only. 
This is a CLOSED BOOK examination 
Any non-programmable calculator is permitted 
No handwritten notes are permitted 
No dictionaries are permitted 
 
ADDITIONAL AUTHORISED MATERIALS EXAMINATION MATERIALS TO BE SUPPLIED 
 




1 x 16 Page Book 
1 x 4-Multiple Choice Answer Sheet 
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Section A 
Multiple Choice Questions 
Total No of Marks for this Section:  50 
 
 
This section should be answered on the Answer Sheet provided.  Please ensure that your name and 
student number have been written on the Answer sheet and placed in the completed Answer Booklet. 
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Section B 
Short Answer Questions 
Total No of Marks for this Section:  50 
 
This section should be answered in the Answer Booklet provided. 
 


















Explain the pathophysiology of delayed haemolytic transfusion reaction. 





Red blood cells used as screening cells for antibody screening and antibody identification are always 
group O. Please explain why. 





What is an antigram? 
 (Marks: 1) 
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Correct evaluation and interpretation of panel results are critical for correct antibody identification. 
Several guidelines have been established to ensure standardised methodology for antibody 
identification.  
 
a) Please explain the purpose of the following guidelines: 
 
i. Inclusion of an autocontrol.  
(Marks: 2) 
ii. Ruling out method. 
(Marks: 2) 
iii. Rule of two. 
(Marks: 2) 
 
b) Applying these guidelines, identify the most likely antibody from the panel below 







Some blood group antigens may display “dosage expression”. 
 
a) Please explain the term “dosage expression” and what causes it. 
 (Marks: 2) 
b) Name two blood group antigens that show dosage expression. 
 (Marks: 2) 
c) Why is dosage expression of relevant to blood banking? 
 (Marks: 3) 
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Haemolytic disease if the foetus & newborn (HDFN) is a potentially life-threatening disorder. 
 
a) Describe the factors that are required for HDFN to occur. 
(Marks: 3) 






Donor blood is processed into different components, which are then stored for blood component 
therapy. 
 
a) Name the different blood components, and briefly describe what they are. 
 (Marks: 8) 
b) List the appropriate storage temperature and expiry for each blood component. 
 (Marks: 4) 
c) For each blood component, list one indication for therapy. 





Quality assurance in blood banking is mandatory to ensure safe blood products for transfusion.  
 




b) What is the difference between quality assurance and quality control. Give two examples for 
each. 
 (Marks: 3) 
 
